International Business Machines Corporation (IBM) rises on reset
International Business Machines Corporation (IBM) rises after investors digest its latest earnings update and lowered 2026 revenue outlook. The rebound follows a sharp post-warning selloff, with shares supported by value metrics, a 3.14% dividend yield, and signs that delayed deals are starting to close.
International Business Machines Corporation (IBM) rises 5.64% as investors buy the dip after the company’s July earnings update and reduced 2026 revenue-growth forecast. The move reflects relief that EPS matched estimates, plus optimism that delayed enterprise deals are starting to close, but the lower outlook still limits the case for a full recovery.
International Business Machines Corporation (IBM) rises 5.64% to $228.48 at 1:00 p.m. ET on July 28, 2026. The rebound follows a sharp earnings-related reset, although the live stock data show relative volume at 0.7x its 200-day average, not above average. That distinction matters because price strength is clear, while unusually broad trading participation is not.
The strongest identifiable catalyst is investor digestion of IBM's July 22 second-quarter results and its reduced 2026 revenue-growth outlook. The move also reflects a possible relief rally after the July 14 warning sent IBM shares sharply lower.
Key Takeaways
IBM rises 5.64% to $228.48, extending a rebound after the July earnings shock.
IBM cut its 2026 revenue-growth forecast to 4% to 5%, down from more than 5%.
Second-quarter EPS came in at $2.93, exactly matching the $2.93 estimate.
The stock trades at a P/E of 19.01 and offers a 3.14% dividend yield, giving the rebound a value and income angle.
Relative volume reads 0.7x the 200-day average, so investors should not treat the move as a confirmed high-volume breakout.
IBM's July Earnings Shock Sets Up Today's Relief Rally
IBM's July 22 earnings update is the central event behind today's repricing. The company reported second-quarter EPS of $2.93 against a $2.93 estimate. That result avoided an earnings miss, but the company reduced its full-year 2026 revenue-growth forecast to 4% to 5%, compared with its earlier outlook for growth above 5%.
The weaker outlook followed IBM's July 14 pre-announcement. Corporate customers had shifted spending toward AI infrastructure, including servers, storage, and memory. That change pressured IBM's software and mainframe-related sales. IBM shares fell 17% in premarket trading after the warning, creating a steep reset in expectations.
Today's gain therefore looks more like post-earnings repair than a fresh product announcement. IBM also said large delayed deals were beginning to close in the third quarter, with about one-third of those deals already completed. That fact gives buyers a concrete timing-based reason to reassess the selloff, even though the lower annual outlook remains in place.
IBM's July 23 agreement to buy HRL Laboratories adds a second narrative. The private quantum research lab is jointly owned by Boeing and General Motors, and the deal supports IBM's two-track quantum strategy. However, the acquisition is strategic and long term. The July 22 earnings reset remains the more direct explanation for today's price action.
IBM Valuation, Earnings Quality, and Dividend Support
IBM's financial profile helps explain why buyers can step in after a sharp decline. The stock has a market capitalization of $215.26B, reported EPS of $11.38, and a P/E ratio of 19.01. It also carries a 3.14% dividend yield. Those figures position IBM differently from high-multiple growth stocks that depend almost entirely on rapid expansion.
The recent earnings record provides another stabilizing factor. IBM beat EPS estimates in six of the last seven reported quarters. The July quarter was the exception, with EPS matching estimates at $2.93. Prior beats included a 5.5% surprise in April 2026 and a 5.4% surprise in January 2026.
Still, valuation is not the same as a bargain. IBM trades at $228.48, well below its 52-week high of $332.46 but above its 52-week low of $199.19. The stock's 0.675 beta also points to a historically lower-volatility profile. That can attract income-focused buyers, yet the lower growth forecast limits the case for a rapid return to the prior high.
Analyst target cuts reinforce that caution. Goldman Sachs lowered its target to $270 from $335 on July 23. Morgan Stanley cut its target to $190 from $293, while Susquehanna reduced its target to $225 from $303. The consensus target remains $267.80, but the wide range from $175 to $350 shows meaningful disagreement over IBM's growth path.
IBM's Hybrid Cloud and AI Position Faces a Spending-Mix Test
IBM operates across Software, Consulting, Infrastructure, and Financing. Its software business includes Red Hat, hybrid cloud, automation, data, and AI tools. Consulting helps customers implement cloud and AI projects, while Infrastructure includes mainframes and other enterprise systems. This mix gives IBM several ways to monetize enterprise technology budgets.
The same mix also creates the current problem. AI investment is reaching infrastructure providers first, while some software and mainframe purchases are taking longer to close. IBM's July warning directly exposed that mismatch. In plain English, customers are spending on the machinery needed to build AI before completing every software purchase that IBM expected.
IBM has invested heavily in its strategic repositioning. Reuters Breakingviews reported that the company spent more than $50B on acquisitions since 2018, including Red Hat, HashiCorp, and Confluent. Those purchases strengthen IBM's hybrid cloud and AI position, but they also raise the standard for execution. Investors need revenue growth to show that the acquired capabilities are becoming a larger economic engine.
The competitive advantage is breadth rather than a single dominant product. IBM can combine software, consulting, infrastructure, and long-standing enterprise relationships. That integrated model supports retention and cross-selling. Yet the 4% to 5% growth forecast shows that breadth has not insulated the company from shifts in corporate spending.
The practical takeaway is to treat today's rise as a reaction to a reset, not proof that the growth issue has vanished. The $228.48 price sits near the $225 target from Susquehanna and below the $267.80 consensus target. That gap offers upside on paper, but the recent target cuts show that analysts are recalibrating rather than simply endorsing a quick recovery.
A disciplined approach favors position sizing over chasing the first rebound. Income investors can point to the 3.14% yield, while value investors can assess the 19.01 P/E against the reduced 4% to 5% growth outlook. Growth-focused investors need evidence that delayed deals continue closing and that AI spending starts lifting IBM's software revenue, rather than only its infrastructure demand.
Volume deserves equal attention. The 0.7x relative-volume reading does not confirm an above-average accumulation day. A separate intraday reading cited 7.35 million shares and described activity as elevated, but the 200-day comparison remains the cleaner benchmark. Until volume expands alongside price, the rebound carries less technical confirmation than the headline gain suggests.
Sentiment has stayed positive despite the guidance cut. IBM's seven-day news sentiment score is 0.9392, versus 0.8932 over 30 days and 0.8263 over 90 days, with the trend rated stable. That supports continued interest, but sentiment can improve faster than fundamentals. The lower forecast and analyst target cuts remain the harder facts.
IBM rises today because investors are digesting a painful July reset and focusing on delayed deals that have started to close. The $2.93 EPS result, 4% to 5% growth outlook, 19.01 P/E, and 3.14% yield create a credible recovery case, but the volume reading does not support an above-average breakout claim.
For investors, IBM is better viewed as a measured income and enterprise-technology position than a momentum trade. The rebound has improved sentiment, yet sustained upside depends on converting AI infrastructure demand into stronger software growth.
IBM is rising as investors digest its July earnings report and look past the lowered 2026 revenue-growth outlook. The stock is also getting a relief-rally boost after the sharp selloff that followed the company’s earlier warning.
+Should I buy IBM stock now?
IBM can appeal to income and value investors because of its dividend yield and moderate valuation, but the reduced growth outlook argues against chasing the move. A better approach is to wait for evidence that delayed deals are closing and revenue growth is reaccelerating.
+Did IBM beat earnings this quarter?
IBM matched analyst expectations with second-quarter EPS of $2.93, so it did not post an earnings miss. The bigger issue was management lowering full-year 2026 revenue-growth guidance to 4% to 5%.
+Is IBM’s rally backed by strong trading volume?
No. Relative volume is running at 0.7x its 200-day average, so the move is not being confirmed by unusually heavy trading. That makes the rebound look more like a post-earnings repair rally than a high-conviction breakout.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on IBM?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
